Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins
- PMID: 8624782
- DOI: 10.1161/01.atv.16.4.591
Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins
Abstract
A novel LDL-associated phospholipase A2 (LDL-PLA2) has been purified to homogeneity from human LDL obtained from plasma apheresis. This enzyme has activity toward both oxidized phosphatidylcholine and platelet activating factor (PAF). A simple purification procedure involving detergent solubilization and affinity and ion exchange chromatography has been devised. Vmax and Km for the purified enzyme are 170 micromol.min-1.mg-1 and 12 micromol/L, respectively. Extensive peptide sequence from LDL-PLA2 facilitated identification of an expressed sequence tag partial cDNA. This has led to cloning and expression of active protein in baculovirus. A lipase motif is also evident from sequence information, indicating that the enzyme is serine dependent. Inhibition by diethyl p-nitrophenyl phosphate and 3,4-dichloroisocoumarin and insensitivity to EDTA, Ca2+, and sulfhydryl reagents confirm that the enzyme is indeed a serine-dependent hydrolase. The protein is extensively glycosylated, and the glycosylation site has been identified. Antibodies to this LDL-PLA2 have been raised and used to show that this enzyme is responsible for >95% of the phospholipase activity associated with LDL. Inhibition of LDL-PLA2 before oxidation of LDL reduces both lysophosphatidylcholine content and monocyte chemoattractant ability of the resulting oxidized LDL. Lysophosphatidylcholine production and monocyte chemoattractant ability can be restored by addition of physiological quantities of pure LDL-PLA2.
Similar articles
-
Expression, purification and characterization of a human serine-dependent phospholipase A2 with high specificity for oxidized phospholipids and platelet activating factor.Biochem J. 1998 Mar 15;330 ( Pt 3)(Pt 3):1309-15. doi: 10.1042/bj3301309. Biochem J. 1998. PMID: 9494101 Free PMC article.
-
Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.J Lipid Res. 1989 Mar;30(3):305-15. J Lipid Res. 1989. PMID: 2723538
-
Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor.Biochem J. 1999 Mar 1;338 ( Pt 2)(Pt 2):479-87. Biochem J. 1999. PMID: 10024526 Free PMC article.
-
Lp-PLA2: an emerging biomarker of coronary heart disease.Expert Rev Mol Diagn. 2002 Jan;2(1):17-22. doi: 10.1586/14737159.2.1.17. Expert Rev Mol Diagn. 2002. PMID: 11963798 Review.
-
The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.Biochim Biophys Acta. 2009 May;1791(5):327-38. doi: 10.1016/j.bbalip.2009.02.015. Biochim Biophys Acta. 2009. PMID: 19272461 Review.
Cited by
-
Apolipoprotein CIII regulates lipoprotein-associated phospholipase A2 expression via the MAPK and NFκB pathways.Biol Open. 2015 Apr 2;4(5):661-5. doi: 10.1242/bio.201410900. Biol Open. 2015. PMID: 25836672 Free PMC article.
-
Effect of the leptin receptor Q223R polymorphism on the host transcriptome following infection with Entamoeba histolytica.Infect Immun. 2013 May;81(5):1460-70. doi: 10.1128/IAI.01383-12. Epub 2013 Feb 19. Infect Immun. 2013. PMID: 23429533 Free PMC article.
-
Lipoprotein associated phospholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: The Atherosclerosis Risk In Communities Study.Atherosclerosis. 2015 Aug;241(2):641-8. doi: 10.1016/j.atherosclerosis.2015.06.033. Epub 2015 Jun 18. Atherosclerosis. 2015. PMID: 26117401 Free PMC article.
-
Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques.Stroke. 2008 May;39(5):1448-55. doi: 10.1161/STROKEAHA.107.503193. Epub 2008 Mar 20. Stroke. 2008. PMID: 18356547 Free PMC article.
-
Secretory phospholipase A2 modified HDL rapidly and potently suppresses platelet activation.Sci Rep. 2017 Aug 14;7(1):8030. doi: 10.1038/s41598-017-08136-1. Sci Rep. 2017. PMID: 28808297 Free PMC article.
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous